United States Patent 5,660,842
Petschow Aug. 26, 1997
Inhibition of helicobacter

Abstract

The present invention is directed to a method for inhibiting Helicobacter by administering C(8) -C(16) monoglycerides of fatty acids or lauric acid. The monoglycerides and/or lauric acid are conveniently administered via a nutritional composition.

 

Inventors: Petschow; Bryon W. (Evansville, IN).
Assignee: Bristol-Myers Squibb Company (Princeton, NJ).
Appl. No.: 435,566
Filed: May 5, 1995

Related U.S. Application Data
Continuation-in-part of Ser No. 317,441, Oct. 4, 1994, abandoned.
Intl. Cl. : A61K 9/36
Current U.S. Cl.: 424/405; 424/440; 424/441; 424/450; 424/451; 424/464
Field of Search: 424/450, 458, 405, 442; 514/2

References Cited | [Referenced By]
U.S. Patent Documents
5,304,540 Apr., 1994 Blackburn et al. 514/2
5,504,072 Apr., 1996 Schmidl et al. 514/2

Foreign Patent Documents
0465423A2 Jun., 1990 EP 31/19
Primary Examiner: Page; Thurman K.
Assistant Examiner: Faulkner; D.
Attorney, Agent or Firm: Savitsky; Thomas R.
35 Claims, 1 Drawing Figures